United States · FDA National Drug Code directory
Levetiracetam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-400_799d949b-b1db-4e10-ab5c-89bf7c1bd308
- Product NDC
- 63323-400
- Form
- INJECTION, SOLUTION
- Composition / generic term
- LEVETIRACETAM
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150813
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVETIRACETAM — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-USE in 1 TRAY (63323-400-05) / 5 mL in 1 VIAL, SINGLE-USE (63323-400-01) · 63323-400-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →